Spire Healthcare Group plc
SPI.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £797 | £749 | £763 | £683 |
| % Growth | 6.4% | -1.8% | 11.7% | – |
| Cost of Goods Sold | £436 | £411 | £472 | £373 |
| Gross Profit | £361 | £338 | £290 | £310 |
| % Margin | 45.3% | 45.1% | 38.1% | 45.4% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £0 | £0 | £223 | £19 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £298 | £272 | £0 | £232 |
| Operating Expenses | £298 | £272 | £223 | £251 |
| Operating Income | £63 | £66 | £67 | £60 |
| % Margin | 7.9% | 8.8% | 8.8% | 8.8% |
| Other Income/Exp. Net | -£52 | -£50 | -£45 | £0 |
| Pre-Tax Income | £11 | £16 | £23 | £14 |
| Tax Expense | £4 | £4 | £9 | -£1 |
| Net Income | £7 | £12 | £13 | £15 |
| % Margin | 0.8% | 1.6% | 1.8% | 2.2% |
| EPS | 0.016 | 0.03 | 0.033 | 0.037 |
| % Growth | -45.6% | -10.2% | -10% | – |
| EPS Diluted | 0.016 | 0.029 | 0.032 | 0.036 |
| Weighted Avg Shares Out | 406 | 403 | 404 | 414 |
| Weighted Avg Shares Out Dil | 406 | 409 | 414 | 417 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | -£44 |
| Interest Expense | £52 | £49 | £49 | £48 |
| Depreciation & Amortization | £34 | £38 | £56 | £54 |
| EBITDA | £109 | £105 | £128 | £115 |
| % Margin | 13.6% | 14.1% | 16.8% | 16.9% |